ComMedX （Computational Medicine Beijing） is a startup that focused on developing next-generation technologies for small-molecules drug discovery. Currently, employees are located in Beijing, China. By combing novel X-ray crystallography/cryo-EM structures, new commercial accessible chemical libraries building, ultra-large docking screening methods, a hierarchical lead optimization pipeline, and the artificial intelligence/machine learning algorithms, ComMed is advancing a new lead discovery platform to boost the first-in-class drugs discovery for biotech companies. ComMed is working to bring innovations for navigating new chemical spaces for new targets at unparalleled low cost and fast speed.